Etherna Is A Belgian Biotechnology Company Founded In 2013Specializing In Mrna Lnplipid Nanoparticletechnology For Therapeutic Applicationsbased In Nielbelgiumthe Company Employs Over 75 Professionals And Focuses On Developing Nucleic Acid Based Medicinesparticularly Immunotherapies For Cancer And Infectious Diseases The Company Offers Proprietary Platforms For Rna Chemistry And Lnp Formulationproviding Integrated Manufacturing Services That Include Research Grade And Gmp Certified Rna Productiontheir Trimix Technology Is A Clinical Stage Immunotherapy Platform Designed To Enhance Immune Responses Against Tumors Or Pathogensadditionallyetherna Develops Customizable Lipid Nanoparticles For Targeted Deliveryimproving Biodistribution To Specific Tissuesthey Collaborate With Pharmaceutical And Biotech Partnerssupporting Projects From Early Stage Research To Late Stage Manufacturing Etherna Operates Advanced Facilities That Support Both Preclinical And Clinical Stage Projectsaiming To Be A Leader In Rna Lnp Technologies And Improve Patient Outcomes Through Innovative Therapeutic Solutions
No conferences found for this company.
| Company Name | Etherna Immunotherapies Nv |
| Country |
Belgium
|
| Address | Galileilaan 19 2845 Niel Belgium |
| Telephone | Login to View |
| Login to View |
